Fu Yu Corporation Limited ( (SG:F13) ) has shared an announcement.
Fu Yu Corporation Limited has reported a significant turnaround in its financial performance for FY2024, with its manufacturing segment achieving an operating profit of S$0.9 million, compared to a loss of S$6.9 million in the previous year. This improvement is attributed to a 10.5% increase in revenue, driven by higher sales in the medical and consumer segments, and a rise in gross profit margin to 13.5%. The company’s EBITDA also saw a substantial increase to S$8.5 million from S$0.6 million in FY2023, reflecting the success of its transformation strategies. Fu Yu’s balance sheet remains robust with a net cash position of S$55.5 million, indicating a strong financial standing.
More about Fu Yu Corporation Limited
YTD Price Performance: -19.23%
Average Trading Volume: 351,556
Technical Sentiment Consensus Rating: Buy
Current Market Cap: S$80.01M
See more data about F13 stock on TipRanks’ Stock Analysis page.